mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.09 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.09 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.09 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.09 |
0.09 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.1 |